Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 132 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Polyzos, S. A., Kountouras J., Shields K., & Mantzoros C. S. (2013).  Irisin: a renaissance in metabolism?. Metabolism. 62(8), 1037-44.
Polyzos, S. A., & Mantzoros C. S. (2018).  Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead.. Metabolism. 78, A4-A9.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.. Curr Mol Med. 9(3), 299-314.
Polyzos, S. A., & Goulis D. G. (2024).  Menopause and metabolic dysfunction-associated steatotic liver disease.. Maturitas. 108024.
Polyzos, S. A., & Mantzoros C. S. (2015).  Leptin in health and disease: facts and expectations at its twentieth anniversary.. Metabolism. 64(1), 5-12.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Efstathiadou Z., Kita M., Arsos G., et al. (2010).  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.. J Bone Miner Metab. 28(6), 706-12.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Polyzos, S. A., Kountouras J., Zavos C., & Tsiaousi E. (2010).  The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.. Diabetes Obes Metab. 12(5), 365-83.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Polyzos, S. A., & Goulas A. (2020).  Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing.. Med Hypotheses. 110379.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Spironolactone revisited.. J Clin Hypertens (Greenwich). 13(10), 783-4.
Polyzos, S. A., Kountouras J., Patsiaoura K., Katsiki E., Zafeiriadou E., Zavos C., et al. (2012).  Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease.. Int J Food Sci Nutr. 63(6), 659-66.
Polyzos, S. A., Makras P., Anastasilakis A. D., Mintziori G., Kita M., Papatheodorou A., et al. (2017).  Periostin and sclerostin levels in juvenile Paget's disease.. Clin Cases Miner Bone Metab. 14(2), 269-271.
Polyzos, S. A., & Mantzoros C. S. (2019).  Obesity: seize the day, fight the fat.. Metabolism. 92, 1-5.
Polyzos, S. A., Lambrinoudaki I., & Goulis D. G. (2022).  Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease.. Hormones (Athens).
Polyzos, S. A., Vachliotis I. D., & Mantzoros C. S. (2023).  Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.. Metabolism. 147, 155676.
Polyzos, S. A., & Mantzoros C. S. (2014).  Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.. Metabolism. 63(2), 161-7.
Polyzos, S. A., & Margioris A. N. (2018).  Sarcopenic obesity.. Hormones (Athens). 17(3), 321-331.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Paget's disease of bone: emphasis on treatment with zoledronic acid.. Expert Rev Endocrinol Metab. 4(5), 423-434.
Polyzos, S. A., & Mantzoros C. S. (2015).  An update on the validity of irisin assays and the link between irisin and hepatic metabolism.. Metabolism. 64(9), 937-42.
Polyzos, S. A., Anastasilakis A. D., Anagnostis P., Kita M., Arsos G., Moralidis E., et al. (2012).  Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.. Endokrynol Pol. 63(4), 312-5.
Polyzos, S. A., Kang E. Seok, Boutari C., Rhee E-J., & Mantzoros C. S. (2020).  Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.. Metabolism. 154203.
Polyzos, S. A., & Anastasilakis A. D. (2010).  Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy.. J Otolaryngol Head Neck Surg. 39(5), 532-41.
Polyzos, S. A., Kountouras J., Polymerou V., Papadimitriou K. G., Zavos C., & Katsinelos P. (2016).   Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 15(5), 705-14.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές